STADA Arzneimittel AG 03.07.2014 13:04 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- On July 01, 2014, LSV Asset Management, Wilmington, Delaware, USA has informed us according to Article 21, Section 1 of the WpHG that via shares its Voting Rights on STADA Arzneimittel AG, Bad Vilbel, Deutschland, have exceeded the 3% threshold of the Voting Rights on June 23, 2014 and on that day amounted to 3.07% (this corresponds to 1856353 Voting Rights). 0.36% of Voting Rights (this corresponds to 219100 Voting Rights) are attributed to the company in accordance with Article 22, Section 1, Sentence 1, No. 1 of the WpHG (German Securities Trading Act). 2.71% of Voting Rights (this corresponds to 1637253 Voting Rights) are attributed to the company in accordance with Article 22, Section 1, Sentence 1, No. 6 of the WpHG (German Securities Trading Act). 03.07.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: STADA Arzneimittel AG StadastraÃe 2-18 61118 Bad Vilbel Germany Internet: www.stada.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: STADA Arzneimittel AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution - Correction of Announcement of 26.6.2014
| Source: EQS Group AG